Literature DB >> 21680684

Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.

Adam M Alessio1, Marla Sammer, Grace S Phillips, Vivek Manchanda, Brandt C Mohr, Marguerite T Parisi.   

Abstract

UNLABELLED: Pediatric (18)F-FDG dosing and acquisition durations are generally based on coarse extrapolation from adult guidelines. This study sought to determine whether shorter acquisition durations or a lower (18)F-FDG injected activity could be used for pediatric (18)F-FDG PET/CT examinations while maintaining diagnostic utility. Reduction of overall scan time potentially reduces motion artifacts, improves patient comfort, and decreases length of sedation. Alternatively, decreased (18)F-FDG dose minimizes radiation risk.
METHODS: Fourteen whole-body (18)F-FDG PET/CT examinations were performed on 13 patients (weight, 13-109 kg; age range, 1-23 y) with a weight-based injected activity (5.3 MBq/kg [0.144 mCi/kg]), fixed acquisition durations (3 min/field of view [FOV] if < 22 kg, 5 min/FOV if > 22 kg), and list-mode acquisition. For each examination, the list-mode data were truncated to form multiple datasets with shorter acquisition durations down to a minimum of 1 min/FOV (i.e., 1, 2, 3, 4, and 5 min/FOV data were formed from single 5 min/FOV acquisition). Fifty-six image volumes were generated, randomized, and reviewed in a masked manner with corresponding CT image volumes by 5 radiologists. Overall, subjective adequacy and objective lesion detection accuracy by body region were evaluated.
RESULTS: All examinations with maximum acquisition duration were graded as adequate and were used as the reference standard for detection accuracy. For patients less than 22 kg, 1 of the 3 PET/CT examinations was graded as inadequate for clinical tasks when acquisition duration was reduced to 2 min/FOV, and all examinations were graded as inadequate when reduced to 1 min/FOV. For patients more than 22 kg, all 3-5 min/FOV studies were graded as adequate, and 2 of the 9 studies were graded as inadequate for 2 min/FOV studies. Lesion detection accuracy was perfect for acquisition times between 3 min/FOV and 5 min/FOV for all regions of the body. However, lesion detection became less accurate when imaging acquisition time was reduced more than 40%.
CONCLUSION: Evaluation of image volumes generated from simulated shorter acquisition durations suggests that imaging times for larger patients (>22 kg) can be reduced from 5 min/FOV to 3 min/FOV without a loss of diagnostic utility. Using decreased acquisition times as a surrogate for (18)F-FDG dose, (18)F-FDG dose can be reduced by approximately 40% when all patients were scanned for 5 min/FOV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680684     DOI: 10.2967/jnumed.110.086579

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Estimated cumulative radiation dose from PET/CT in children with malignancies.

Authors:  Michael J Gelfand; Susan E Sharp; S Ted Treves; Frederic H Fahey; Marguerite T Parisi; Adam M Alessio
Journal:  Pediatr Radiol       Date:  2010-08-13

2.  Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT.

Authors:  Yu-Mo Zhao; Ying-He Li; Tao Chen; Wei-Guang Zhang; Lin-Hao Wang; Jiatai Feng; Chenwei Li; Xu Zhang; Wei Fan; Ying-Ying Hu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-18       Impact factor: 9.236

3.  Quantitative analysis of image metrics for reduced and standard dose pediatric 18F-FDG PET/MRI examinations.

Authors:  Pietro Zucchetta; Marco Branchini; Alessandra Zorz; Valentina Bodanza; Diego Cecchin; Marta Paiusco; Franco Bui
Journal:  Br J Radiol       Date:  2019-01-23       Impact factor: 3.039

4.  Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.

Authors:  Michael Lassmann; S Ted Treves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-06       Impact factor: 9.236

5.  New EANM paediatric dosage card: optimization of F-18 FDG-administered activities.

Authors:  Gilles Metrard; Hélène Besse; Diane Darsin-Bettinger; Sofiane Mouzoune; Sabine Gauvain
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-04       Impact factor: 9.236

6.  Pediatric Radiopharmaceutical Administration: harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the 2010 North American Consensus guideline.

Authors:  Michael Lassmann; S Ted Treves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08       Impact factor: 9.236

7.  Quantitative and Qualitative Improvement of Low-Count [68Ga]Citrate and [90Y]Microspheres PET Image Reconstructions Using Block Sequential Regularized Expectation Maximization Algorithm.

Authors:  Youngho Seo; Mohammad Mehdi Khalighi; Kristen A Wangerin; Timothy W Deller; Yung-Hua Wang; Salma Jivan; Maureen P Kohi; Rahul Aggarwal; Robert R Flavell; Spencer C Behr; Michael J Evans
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

8.  Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI.

Authors:  Sergios Gatidis; Holger Schmidt; Christian la Fougère; Konstantin Nikolaou; Nina F Schwenzer; Jürgen F Schäfer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-26       Impact factor: 9.236

Review 9.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

10.  A dedicated paediatric [18F]FDG PET/CT dosage regimen.

Authors:  Christina P W Cox; Daniëlle M E van Assema; Frederik A Verburg; Tessa Brabander; Mark Konijnenberg; Marcel Segbers
Journal:  EJNMMI Res       Date:  2021-07-19       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.